Article Information
History
- September 6, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- J. Bradley Layton1,#,
- Arnstein Lindaas2,
- Stella G Muthuri3,*,
- Patricia C. Lloyd4,
- Morgan M. Richey1,*,
- Joann F. Gruber4,
- Hai Lyu2,
- Mollie M. McKillop3,*,
- Lisa S. Kowarski3,*,
- Christine Bui1,
- Shelby S. Fisher5,
- Tainya C. Clarke4,
- Angela S. Cheng2,*,
- Zhiruo Wan2,
- Pablo Freyria Duenas2,
- Yangping Chen2,
- Timothy Burrell3,
- Minya Sheng3,*,
- Azadeh Shoaibi4,*,
- Yoganand Chillarige2,
- Jeffrey Beers3,
- Mary S. Anthony1,
- Richard A. Forshee4 and
- Steven A. Anderson4
- 1RTI Health Solutions, Research Triangle Park, NC, USA;
- 2Acumen LLC, USA;
- 3IBM Consulting, Bethesda, MD, USA;
- 4US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA;
- 5RTI International, Research Triangle Park, NC, USA
- ↵#Correspondence
: J. Bradley Layton RTI Health Solutions, 3040 East Cornwallis Rd, PO Box 12194, Research Triangle Park, North Carolina, USA 27709 Office: +1.919.541.8885 Fax: +1.919.541.7222 jblayton{at}rti.org
Posted September 06, 2024.
Evaluating the Risk of Cardiovascular Adverse Events and Appendicitis After COVID-19 Diagnosis in Adults in the United States: Implications of the Start of Follow-Up
